ILS Clinical Research
Mexico City, Mexico· Est.
Mexico's leading CRO delivering integrated clinical trial services with AI‑enhanced data insights.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Mexico's leading CRO delivering integrated clinical trial services with AI‑enhanced data insights.
OncologyCardiovascularNeurologyImmunology
Technology Platform
Proprietary CTMS integrating eCRFs, remote monitoring, and AI‑driven data quality analytics to enable risk‑based monitoring and decentralized trial execution.
Opportunities
Expansion into decentralized clinical trials and broader geographic coverage across Latin America can drive new sponsor contracts and higher revenue.
Risk Factors
Regulatory variability across countries and competition from larger global CROs may pressure margins and client retention.
Competitive Landscape
ILS competes with regional CROs and multinational firms like IQVIA and Parexel; its differentiation lies in AI‑enhanced analytics and cost‑effective services tailored to Latin American sites.